Kibow Biotech is a World Trade Center of Greater Philadelphia Member
NEWTOWN SQUARE, Pa., Nov. 12, 2015 /PRNewswire/ -- This year's annual American society of Nephrology (ASN) 2015 Kidney Week conference was held at the San Diego Convention Center, Nov 3 – 8. Kibow Biotech, Inc. was pleased to mark its 10th year of continuous participation as an exhibitor and to increase awareness and understanding of its "Enteric Dialysis™ or Uremic Toxin Reduction Technology" concept. The company's technology is based on modulating the Gut Microbiome with its dietary supplement product made with the company's technology is based on modulating the Gut Microbiome with its dietary supplement product made with specific strains of Probiotics and selected Prebiotics towards modulation and stabilization of GUT MICROBIOME towards Kidney Failure Problems.
The company also participated in the 3rd World Congress on Targeting Gut Microbiota towards clinical revolution which was held at the Pasteur Institute, Paris from Oct 21-23. Representing Kibow, Dr. Natarajan Ranganathan gave an oral presentation on the same "Enteric Dialysis Concept" and Gut-Kidney connection. The presentation was well received and recognized among all the medical, scientific, and clinical researchers from several countries.